Is Serum TGF-β1 and TGF-β2 levels Correlated to Children with Autism Intensity?
Iranian Journal of Child Neurology,
Vol. 15 No. 2 (2021),
8 March 2021
Transforming growth factor-beta (TGF-β), a group of multifunctional growth factors, plays an important role in the neuron survival and neurodevelopmental functions. Some studies have evaluated the correlation between TGF-β1 and TGF-β2 abnormalities and autism spectrum disorders. In this study, we compared the TGF-β1 and
TGF-β2 levels between autistic and intellectually normal individuals.
Materials & Methods
The study population consisted of 39 autistic and 30 age-matched intellectually normal individuals (control group). Blood samples were taken from all individuals, and all patients were divided into 2 groups (mild-to-moderate and severe) according to the childhood autism rating scale. The cytokines levels were measured by Enzyme Linked Immunosorbent Assay (ELISA).
The mean concentration of TGF-β1 was signiﬁcantly lower (P < 0.0001) in children with autism compared to the control group (25.3 ± 6.5 versus 35.1 ± 9.4 ng/mL, respectively). Also, the mean concentration of TGF-β2 in children with autism (32.35± 7.75 ng/mL) was higher compared to those in the control group (30.47± 4.36 ng/mL); however, this difference did not reach statistical significance (P = 0.21). A positive correlation was observed between TGF-β1 concentration and autism severity (r = 0.41; P = 0.02), whereas a negative correlation was found between TGF-β2 concentration andautism severity (r = -0.41; P = 0.02).
The results of the present investigation suggest that there is a decrease in the levels of TGF-β1 in the serum of patients with autism and this cytokine may be effective in the treatment of the pathophysiological aspects of autism.
- Autism spectrum disorder; Neurodevelopmental factors; Transforming growth factor-Beta; Autism intensity
How to Cite
Bertoglio K, Hendren RL. New developmentsin autism. Psychiatric Clinics of North America.
Gibbs V, Aldridge F, Sburlati E, Chandler F, Smith K, Cheng L. Missed opportunities: An investigation of pathways to autism diagnosis in Australia. Research in Autism Spectrum Disorders. 2019;57:55-62.
Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z, et al. Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. MMWR Surveillance Summaries. 2018;67(6):1.
Grzadzinski R, Huerta M, Lord C. DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes. Molecular autism. 2013;4(1):12.
Sajdel-Sulkowska EM, Xu M, McGinnis W, Koibuchi N. Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). The Cerebellum. 2011;10(1):43-8.
Kałużna-Czaplińska J, Jóźwik-Pruska J. Chromatographic and mass spectrometric techniques in studies on oxidative stress in autism. Journal of Chromatography B. 2016;1019:4-14.
DeThorne LS, Ceman S. Genetic Testing and Autism: Tutorial for Communication Sciences and Disorders. Journal of communication disorders. 2018.
Ashwood P, Wills S, Van de Water J. The immune response in autism: a new frontier for
autism research. Journal of leukocyte biology. 2006;80(1):1-15.
Edmiston E, Ashwood P, Van de Water J.Autoimmunity, autoantibodies, and autism spectrum disorder. Biological psychiatry. 2017;81(5):383-90.
Gomes FCA, de Oliveira Sousa V, Romão L. Emerging roles for TGF-β1 in nervous system development. International Journal of Developmental Neuroscience. 2005;23(5):413-24.
Doenyas C. Gut microbiota, inflammation, and probiotics on neural development in autism spectrum disorder. Neuroscience. 2018.
Ziemssen T, Kern S. Psychoneuroimmunology– cross-talk between the immune and nervous systems. Journal of neurology. 2007;254(2):II8- II11.
Han S, Tai C, Jones CJ, Scheuer T, Catterall WA. Enhancement of inhibitory neurotransmission by GABA A receptors having α 2, 3-subunits ameliorates behavioral deficits in a mouse model of autism. Neuron. 2014;81(6):1282-9.
Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL, Hertz-Picciotto I, et al. Neonatal cytokine profiles associated with autism spectrum disorder. Biological psychiatry. 2017;81(5):442-51.
Deverman BE, Patterson PH. Cytokines and CNS development. Neuron. 2009;64(1):61-78.
Verburg-van Kemenade B, Van der Aa LM, Chadzinska M. Neuroendocrine–immune interaction: regulation of inflammation via G-protein coupled receptors. General and comparative endocrinology. 2013;188:94-101.
Zhang J, Niu N, Li B, McNutt MA. Neuron-derived IgG protects neurons from complement-dependent cytotoxicity. Journal of Histochemistry & Cytochemistry. 2013;61(12):869-79.
Wrzesinski SH, Wan YY, Flavell RA. Transforming growth factor-β and the immune response: implications for anticancer therapy. Clinical cancer research. 2007;13(18):5262-70.
Kropf J, Schurek JO, Wollner A, Gressner AM. Immunological measurement of transforming growth factor-beta 1 (TGF-β1) in blood; assay development and comparison. Clinical chemistry. 1997;43(10):1965-74.
Li X, Mai J, Virtue A, Yin Y, Gong R, Sha X, et al. IL-35 is a novel responsive antiinflammatory cytokine—a new system ofcategorizing anti-inflammatory cytokines. PloS one. 2012;7(3):e33628.
Wu J, Xie A, Chen W. Cytokine regulation of immune tolerance. Burns & trauma. 2014;2(1):11.
Fuentes-Medel Y, Ashley J, Barria R, Maloney R, Freeman M, Budnik V. Integration of a retrograde signal during synapse formation by glia-secreted TGF-β ligand. Current Biology. 2012;22(19):1831-8.
Han G, Li F, Singh TP, Wolf P, Wang X-J. The pro-inflammatory role of TGFβ1: a paradox? International journal of biological sciences. 2012;8(2):228.
Goines P, Van de Water J. The immune system’s role in the biology of autism. Current opinion in neurology. 2010;23(2):111.
Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, et al. Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in
clinical behavioral outcomes. Journal of neuroimmunology.2008;204(21):149-53.
. El-Ansary A, Al-Ayadhi L. Neuroinflammation in autism spectrum disorders. Journal ofneuroinflammation. 2012;9(1):265.
Vargas DL, Nascimbene C, Krishnan C,Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 2005;57(1):67-81.
Alabdali A, Al-Ayadhi L, El-Ansary A. A key role for an impaired detoxification mechanism in the etiology and severity of autism spectrum disorders. Behavioral and Brain Functions. 2014;10(1):1.
Buch MH, Seto Y, Bingham SJ, Bejarano V, Bryer D, White J, et al. C‐reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent
response to etanercept. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2005;52(1):42-8.
Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). Journal of autism and developmental disorders. 1980;10(1):91-103.
Zhou X, Fragala MS, McElhaney JE, Kuchel GA. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Current opinion in clinical nutrition and metabolic care.
Finnson KW, McLean S, Di Guglielmo GM, Philip A. Dynamics of transforming growth factor beta signaling in wound healing and scarring. Advances in wound care. 2013;2(5):195-214.
Rautava S, Lu L, Nanthakumar NN, Dubert- Ferrandon A, Walker WA. TGF-β2 induces maturation of immature human intestinal epithelial cells and inhibits inflammatory cytokine responses induced via the NF-κB pathway. Journal of pediatric gastroenterology and nutrition. 2012;54(5):630.
Eftekharian MM, Ghafouri-Fard S, Noroozi R, Omrani MD, Arsang-jang S, Ganji M, et al. Cytokine profile in autistic patients. Cytokine. 2018;108:120-6.
Carlson ME, Conboy MJ, Hsu M, Barchas L, Jeong J, Agrawal A, et al. Relative roles of TGF‐β1 and Wnt in the systemic regulation and aging of satellite cell responses. Aging cell. 2009;8(6):676-89.
- Abstract Viewed: 33 times
- PDF Downloaded: 0 times